HURA
TuHURA Biosciences Inc
NASDAQ: HURA · HEALTHCARE · BIOTECHNOLOGY
$2.10
-1.41% today
Updated 2026-04-29
Market cap
$141.14M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.63
Dividend yield
—
52W range
$0 – $4
Volume
1.1M
TuHURA Biosciences Inc (HURA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2010 | 2011 | 2012 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | — | — | $4.32M | $2.58M | $6.36M | $7.91M | $7.07M | $4.04M | $2.94M | $13.54M | $6.40M | $15.20M | $4.36M | $19.97M |
| Cash & equivalents | — | — | — | $4.14M | $1.75M | $6.16M | $6.59M | $5.97M | $3.72M | $2.39M | $10.54M | $5.55M | $14.25M | $3.67M | $12.66M |
| Current assets | — | — | — | $4.32M | $2.03M | $6.32M | $7.87M | $7.05M | $4.03M | $2.76M | $11.79M | $5.68M | $14.74M | $4.16M | $19.61M |
| Total liabilities | — | — | — | $5.14M | $3.40M | $1.50M | $1.33M | $1.64M | $2.07M | $2.67M | $2.96M | $7.15M | $2.89M | $5.92M | $5.37M |
| Current liabilities | — | — | — | $249487.00 | $853085.00 | $627446.00 | $1.30M | $1.64M | $2.07M | $2.67M | $2.78M | $7.15M | $2.87M | $3.60M | $5.33M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — | — | $2.32M | — |
| Shareholder equity | — | — | — | $-817978.00 | $-821490.00 | $4.86M | $6.58M | $5.44M | $1.97M | $263000.00 | $10.58M | $-747821.00 | $12.30M | $-1.56M | $14.59M |
| Retained earnings | — | — | — | $-15.86M | $-18.61M | $-32.24M | $-41.12M | $-52.44M | $-60.58M | $-69.72M | $-111.22M | $-49.48M | $-59.16M | $-88.47M | $-111.12M |
| Accounts receivable | — | — | — | $11062.00 | $25831.00 | $18387.00 | $76595.00 | $39519.00 | $26187.00 | — | — | — | $101424.00 | $334443.00 | $222702.00 |
| Inventory | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $214699.00 |
| Goodwill | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |